Rank | Gene Set | Z-score |
---|---|---|
1 | DNA deamination (GO:0045006) | 7.44299067 |
2 | cytidine metabolic process (GO:0046087) | 6.68351409 |
3 | cytidine catabolic process (GO:0006216) | 6.68351409 |
4 | cytidine deamination (GO:0009972) | 6.68351409 |
5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.04516117 |
6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.89321238 |
7 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.19372153 |
8 | protein neddylation (GO:0045116) | 5.10398559 |
9 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.09192857 |
10 | regulation of chronic inflammatory response (GO:0002676) | 4.36449068 |
11 | cellular response to interleukin-15 (GO:0071350) | 4.34605308 |
12 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.29617243 |
13 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.08224442 |
14 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.08224442 |
15 | sequestering of actin monomers (GO:0042989) | 3.99325641 |
16 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.95650947 |
17 | proteasome assembly (GO:0043248) | 3.88170952 |
18 | actin nucleation (GO:0045010) | 3.84167506 |
19 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.80374251 |
20 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.54125269 |
21 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.52378390 |
22 | L-fucose catabolic process (GO:0042355) | 3.49707547 |
23 | fucose catabolic process (GO:0019317) | 3.49707547 |
24 | L-fucose metabolic process (GO:0042354) | 3.49707547 |
25 | negative regulation of T cell apoptotic process (GO:0070233) | 3.49048189 |
26 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.43165776 |
27 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.42361377 |
28 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.42361377 |
29 | positive regulation of cell killing (GO:0031343) | 3.42330281 |
30 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.42202573 |
31 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.42202573 |
32 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.42202573 |
33 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.37983484 |
34 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.37750060 |
35 | response to interleukin-15 (GO:0070672) | 3.36694460 |
36 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.30971051 |
37 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.29795604 |
38 | ATP synthesis coupled proton transport (GO:0015986) | 3.29795604 |
39 | regulation of regulatory T cell differentiation (GO:0045589) | 3.27573605 |
40 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.22609582 |
41 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.22609582 |
42 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.19625529 |
43 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.19216261 |
44 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.17503633 |
45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.11537539 |
46 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.07772227 |
47 | regulation of cell killing (GO:0031341) | 3.05636206 |
48 | response to pheromone (GO:0019236) | 3.03687454 |
49 | negative regulation by host of viral transcription (GO:0043922) | 3.01930515 |
50 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.00368044 |
51 | positive regulation of interleukin-17 production (GO:0032740) | 2.99566074 |
52 | positive regulation of defense response to virus by host (GO:0002230) | 2.99106427 |
53 | negative regulation of ligase activity (GO:0051352) | 2.96507539 |
54 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.96507539 |
55 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.95822153 |
56 | protein deneddylation (GO:0000338) | 2.94957810 |
57 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.90317780 |
58 | eosinophil chemotaxis (GO:0048245) | 2.89680503 |
59 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.89256219 |
60 | negative T cell selection (GO:0043383) | 2.88420450 |
61 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.87552327 |
62 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.86669292 |
63 | cullin deneddylation (GO:0010388) | 2.85677306 |
64 | regulation of interleukin-8 secretion (GO:2000482) | 2.85137304 |
65 | positive regulation of tolerance induction (GO:0002645) | 2.80398400 |
66 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.80395615 |
67 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.76915035 |
68 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.76915035 |
69 | activated T cell proliferation (GO:0050798) | 2.76444059 |
70 | positive regulation of ligase activity (GO:0051351) | 2.76156238 |
71 | DNA double-strand break processing (GO:0000729) | 2.74350649 |
72 | mast cell activation (GO:0045576) | 2.73388355 |
73 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.72330883 |
74 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.69378087 |
75 | positive regulation of cell cycle arrest (GO:0071158) | 2.68944352 |
76 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.68481262 |
77 | regulation of cellular amine metabolic process (GO:0033238) | 2.68401114 |
78 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.67408887 |
79 | negative regulation of telomere maintenance (GO:0032205) | 2.63831998 |
80 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.62718081 |
81 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.62496497 |
82 | interferon-gamma production (GO:0032609) | 2.61829880 |
83 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.61084657 |
84 | eosinophil migration (GO:0072677) | 2.60548559 |
85 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.60547507 |
86 | regulation of activation of Janus kinase activity (GO:0010533) | 2.59830710 |
87 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.58490937 |
88 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.58387217 |
89 | negative regulation of mast cell activation (GO:0033004) | 2.58127632 |
90 | electron transport chain (GO:0022900) | 2.57513132 |
91 | respiratory electron transport chain (GO:0022904) | 2.56500345 |
92 | T cell receptor signaling pathway (GO:0050852) | 2.55208320 |
93 | regulation of T cell apoptotic process (GO:0070232) | 2.54974391 |
94 | negative regulation of viral genome replication (GO:0045071) | 2.52775744 |
95 | response to interferon-beta (GO:0035456) | 2.52196923 |
96 | platelet dense granule organization (GO:0060155) | 2.51552061 |
97 | natural killer cell activation (GO:0030101) | 2.50742975 |
98 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.50295870 |
99 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.50113062 |
100 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.47016592 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.75879644 |
2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.51756961 |
3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.44532436 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.42061806 |
5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.33537128 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.30556895 |
7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.27426779 |
8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.06717518 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.05673404 |
10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.88452479 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.75452946 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.75360105 |
13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.73730642 |
14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.50181911 |
15 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.38927226 |
16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.32746575 |
17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.28336356 |
18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.24310074 |
19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.23899073 |
20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.21686445 |
21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.18430409 |
22 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.02379825 |
23 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.97944473 |
24 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.95815735 |
25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.93477956 |
26 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.87335568 |
27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.85023875 |
28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.79976200 |
29 | MYB_26560356_Chip-Seq_TH2_Human | 1.77815156 |
30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.76358574 |
31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71869623 |
32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.70289069 |
33 | GATA3_26560356_Chip-Seq_TH2_Human | 1.70193738 |
34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.66890377 |
35 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.63230600 |
36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.60451541 |
37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59422284 |
38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58279417 |
39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.56132578 |
40 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.55693221 |
41 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.53353700 |
42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47193069 |
43 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.44453370 |
44 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.44248932 |
45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43825428 |
46 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38266407 |
47 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37087484 |
48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36083709 |
49 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30955218 |
50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29640526 |
51 | AR_20517297_ChIP-Seq_VCAP_Human | 1.29087724 |
52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.28461900 |
53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.27605772 |
54 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.26808037 |
55 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.26370870 |
56 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.25791576 |
57 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.24143416 |
58 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.24143416 |
59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.23339776 |
60 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.23093595 |
61 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19467593 |
62 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.19264738 |
63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.18407730 |
64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17574364 |
65 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.16108293 |
66 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.16108293 |
67 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13749670 |
68 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13641637 |
69 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.13410447 |
70 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13355798 |
71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11744752 |
72 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.11072917 |
73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.10790267 |
74 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.08602666 |
75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08118811 |
76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07862512 |
77 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06578401 |
78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06197122 |
79 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.05908803 |
80 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.05347834 |
81 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.05006073 |
82 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.04713486 |
83 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.02054781 |
84 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00930768 |
85 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.97135376 |
86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96517175 |
87 | MYB_26560356_Chip-Seq_TH1_Human | 0.95895782 |
88 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.95640358 |
89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.95384407 |
90 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.94660212 |
91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94373117 |
92 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91263592 |
93 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91188838 |
94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.90283550 |
95 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.89630749 |
96 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.88978876 |
97 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.88066454 |
98 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.87464850 |
99 | NCOR_22424771_ChIP-Seq_293T_Human | 0.86421914 |
100 | GATA3_26560356_Chip-Seq_TH1_Human | 0.86013169 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005671_abnormal_response_to | 5.37198658 |
2 | MP0002102_abnormal_ear_morphology | 3.39389026 |
3 | MP0001835_abnormal_antigen_presentation | 3.15534971 |
4 | MP0003763_abnormal_thymus_physiology | 2.89155871 |
5 | MP0009785_altered_susceptibility_to | 2.68994452 |
6 | MP0005000_abnormal_immune_tolerance | 2.45019523 |
7 | MP0002166_altered_tumor_susceptibility | 2.44486128 |
8 | MP0009333_abnormal_splenocyte_physiolog | 2.39571773 |
9 | MP0001873_stomach_inflammation | 2.37257896 |
10 | MP0005360_urolithiasis | 2.32740973 |
11 | MP0001800_abnormal_humoral_immune | 2.23441157 |
12 | MP0000685_abnormal_immune_system | 2.20026751 |
13 | MP0005387_immune_system_phenotype | 2.16933359 |
14 | MP0001790_abnormal_immune_system | 2.16933359 |
15 | MP0000372_irregular_coat_pigmentation | 2.16391443 |
16 | MP0008872_abnormal_physiological_respon | 2.13101853 |
17 | MP0002138_abnormal_hepatobiliary_system | 2.07379635 |
18 | MP0002723_abnormal_immune_serum | 1.94586344 |
19 | MP0002420_abnormal_adaptive_immunity | 1.93765969 |
20 | MP0002148_abnormal_hypersensitivity_rea | 1.91956119 |
21 | MP0006082_CNS_inflammation | 1.87223072 |
22 | MP0003786_premature_aging | 1.86164647 |
23 | MP0001348_abnormal_lacrimal_gland | 1.85217807 |
24 | MP0001819_abnormal_immune_cell | 1.83660066 |
25 | MP0002006_tumorigenesis | 1.83593098 |
26 | MP0005464_abnormal_platelet_physiology | 1.82392456 |
27 | MP0002876_abnormal_thyroid_physiology | 1.77938862 |
28 | MP0002736_abnormal_nociception_after | 1.73144702 |
29 | MP0001986_abnormal_taste_sensitivity | 1.71044849 |
30 | MP0008877_abnormal_DNA_methylation | 1.70139540 |
31 | MP0002452_abnormal_antigen_presenting | 1.67608295 |
32 | MP0002398_abnormal_bone_marrow | 1.67430602 |
33 | MP0003866_abnormal_defecation | 1.64165612 |
34 | MP0006072_abnormal_retinal_apoptosis | 1.61326718 |
35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.60644194 |
36 | MP0000689_abnormal_spleen_morphology | 1.59286489 |
37 | MP0005025_abnormal_response_to | 1.57454021 |
38 | MP0000716_abnormal_immune_system | 1.51506805 |
39 | MP0001968_abnormal_touch/_nociception | 1.47784653 |
40 | MP0001501_abnormal_sleep_pattern | 1.47295617 |
41 | MP0010155_abnormal_intestine_physiology | 1.42706260 |
42 | MP0003646_muscle_fatigue | 1.40298100 |
43 | MP0001845_abnormal_inflammatory_respons | 1.39880983 |
44 | MP0000703_abnormal_thymus_morphology | 1.39597992 |
45 | MP0001905_abnormal_dopamine_level | 1.38646746 |
46 | MP0002722_abnormal_immune_system | 1.35035232 |
47 | MP0005084_abnormal_gallbladder_morpholo | 1.34434837 |
48 | MP0004043_abnormal_pH_regulation | 1.34397677 |
49 | MP0006036_abnormal_mitochondrial_physio | 1.33836190 |
50 | MP0005075_abnormal_melanosome_morpholog | 1.33492819 |
51 | MP0004742_abnormal_vestibular_system | 1.30395006 |
52 | MP0010386_abnormal_urinary_bladder | 1.27855334 |
53 | MP0009697_abnormal_copulation | 1.27587488 |
54 | MP0002638_abnormal_pupillary_reflex | 1.26569477 |
55 | MP0002429_abnormal_blood_cell | 1.24398631 |
56 | MP0001661_extended_life_span | 1.17804539 |
57 | MP0003011_delayed_dark_adaptation | 1.13160371 |
58 | MP0005410_abnormal_fertilization | 1.11032679 |
59 | MP0004142_abnormal_muscle_tone | 1.10051841 |
60 | MP0005645_abnormal_hypothalamus_physiol | 1.06936093 |
61 | MP0005253_abnormal_eye_physiology | 1.05999219 |
62 | MP0003183_abnormal_peptide_metabolism | 1.05886633 |
63 | MP0002933_joint_inflammation | 1.05454231 |
64 | MP0003806_abnormal_nucleotide_metabolis | 1.04209196 |
65 | MP0002405_respiratory_system_inflammati | 1.03791634 |
66 | MP0002163_abnormal_gland_morphology | 1.03149802 |
67 | MP0005551_abnormal_eye_electrophysiolog | 1.02909215 |
68 | MP0004145_abnormal_muscle_electrophysio | 1.00418102 |
69 | MP0005646_abnormal_pituitary_gland | 1.00388690 |
70 | MP0002837_dystrophic_cardiac_calcinosis | 0.98848607 |
71 | MP0006035_abnormal_mitochondrial_morpho | 0.96147785 |
72 | MP0005379_endocrine/exocrine_gland_phen | 0.94221252 |
73 | MP0003880_abnormal_central_pattern | 0.94043306 |
74 | MP0002909_abnormal_adrenal_gland | 0.91277578 |
75 | MP0003252_abnormal_bile_duct | 0.89883930 |
76 | MP0002419_abnormal_innate_immunity | 0.87954790 |
77 | MP0004147_increased_porphyrin_level | 0.87482536 |
78 | MP0008007_abnormal_cellular_replicative | 0.86781330 |
79 | MP0009745_abnormal_behavioral_response | 0.86743838 |
80 | MP0003436_decreased_susceptibility_to | 0.86729280 |
81 | MP0005310_abnormal_salivary_gland | 0.86597234 |
82 | MP0002693_abnormal_pancreas_physiology | 0.84987717 |
83 | MP0002272_abnormal_nervous_system | 0.84817269 |
84 | MP0003448_altered_tumor_morphology | 0.84260407 |
85 | MP0005636_abnormal_mineral_homeostasis | 0.81815510 |
86 | MP0008469_abnormal_protein_level | 0.80454501 |
87 | MP0009763_increased_sensitivity_to | 0.80211938 |
88 | MP0001764_abnormal_homeostasis | 0.79910780 |
89 | MP0001984_abnormal_olfaction | 0.79358012 |
90 | MP0003724_increased_susceptibility_to | 0.78539862 |
91 | MP0002234_abnormal_pharynx_morphology | 0.78305044 |
92 | MP0000465_gastrointestinal_hemorrhage | 0.77928421 |
93 | MP0004084_abnormal_cardiac_muscle | 0.77070257 |
94 | MP0006276_abnormal_autonomic_nervous | 0.75928828 |
95 | MP0001919_abnormal_reproductive_system | 0.74199696 |
96 | MP0000538_abnormal_urinary_bladder | 0.74163276 |
97 | MP0005167_abnormal_blood-brain_barrier | 0.71746542 |
98 | MP0002733_abnormal_thermal_nociception | 0.71030363 |
99 | MP0009764_decreased_sensitivity_to | 0.69542919 |
100 | MP0009046_muscle_twitch | 0.69226842 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Aplastic anemia (HP:0001915) | 5.29819319 |
2 | T lymphocytopenia (HP:0005403) | 5.10093739 |
3 | Abnormality of T cell number (HP:0011839) | 5.01934934 |
4 | Abnormality of B cell number (HP:0010975) | 4.47608433 |
5 | B lymphocytopenia (HP:0010976) | 4.40582365 |
6 | Severe combined immunodeficiency (HP:0004430) | 4.30731844 |
7 | IgG deficiency (HP:0004315) | 4.12745953 |
8 | Chronic diarrhea (HP:0002028) | 3.95161916 |
9 | Increased IgM level (HP:0003496) | 3.82173984 |
10 | Thyroiditis (HP:0100646) | 3.75689478 |
11 | Renal cortical cysts (HP:0000803) | 3.63900125 |
12 | Abnormality of T cells (HP:0002843) | 3.59668648 |
13 | Acute necrotizing encephalopathy (HP:0006965) | 3.57540870 |
14 | Dyschromatopsia (HP:0007641) | 3.46287851 |
15 | Combined immunodeficiency (HP:0005387) | 3.37682870 |
16 | Autoimmune hemolytic anemia (HP:0001890) | 3.35906023 |
17 | Mitochondrial inheritance (HP:0001427) | 3.33105308 |
18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.30396202 |
19 | Increased CSF lactate (HP:0002490) | 3.20891804 |
20 | Acute encephalopathy (HP:0006846) | 3.14518616 |
21 | Hypoproteinemia (HP:0003075) | 3.12576138 |
22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.11980601 |
23 | Abnormality of eosinophils (HP:0001879) | 3.09648534 |
24 | Hepatic necrosis (HP:0002605) | 3.07475978 |
25 | Abnormality of the prostate (HP:0008775) | 3.01984333 |
26 | Hepatocellular necrosis (HP:0001404) | 2.98271323 |
27 | Progressive macrocephaly (HP:0004481) | 2.94281567 |
28 | Abnormality of the renal cortex (HP:0011035) | 2.84118061 |
29 | Generalized aminoaciduria (HP:0002909) | 2.76404042 |
30 | Abolished electroretinogram (ERG) (HP:0000550) | 2.73234009 |
31 | Joint swelling (HP:0001386) | 2.71375473 |
32 | Pancytopenia (HP:0001876) | 2.66539501 |
33 | Increased hepatocellular lipid droplets (HP:0006565) | 2.65912640 |
34 | 3-Methylglutaconic aciduria (HP:0003535) | 2.65655476 |
35 | Increased serum lactate (HP:0002151) | 2.60166001 |
36 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58030577 |
37 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.56743362 |
38 | Abnormality of alanine metabolism (HP:0010916) | 2.56743362 |
39 | Hyperalaninemia (HP:0003348) | 2.56743362 |
40 | Stomatitis (HP:0010280) | 2.50782177 |
41 | Hypomagnesemia (HP:0002917) | 2.47748872 |
42 | Pancreatic cysts (HP:0001737) | 2.46359755 |
43 | Eosinophilia (HP:0001880) | 2.42552881 |
44 | Optic disc pallor (HP:0000543) | 2.38369473 |
45 | Abnormality of T cell physiology (HP:0011840) | 2.38197586 |
46 | Renal Fanconi syndrome (HP:0001994) | 2.31476675 |
47 | Cerebral edema (HP:0002181) | 2.29303485 |
48 | Abnormality of midbrain morphology (HP:0002418) | 2.26933843 |
49 | Molar tooth sign on MRI (HP:0002419) | 2.26933843 |
50 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.26387188 |
51 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.23221408 |
52 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.21218991 |
53 | Increased intramyocellular lipid droplets (HP:0012240) | 2.20980129 |
54 | Encephalitis (HP:0002383) | 2.20933781 |
55 | Prostate neoplasm (HP:0100787) | 2.20007171 |
56 | Congenital, generalized hypertrichosis (HP:0004540) | 2.18495179 |
57 | Hypothermia (HP:0002045) | 2.17441971 |
58 | Tongue fasciculations (HP:0001308) | 2.16022650 |
59 | Abnormality of magnesium homeostasis (HP:0004921) | 2.14985372 |
60 | Lactic acidosis (HP:0003128) | 2.14527268 |
61 | Leukocytosis (HP:0001974) | 2.13452928 |
62 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.09746744 |
63 | Recurrent cutaneous fungal infections (HP:0011370) | 2.09746744 |
64 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.09593042 |
65 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.09593042 |
66 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.09536821 |
67 | Exertional dyspnea (HP:0002875) | 2.07300201 |
68 | Retrobulbar optic neuritis (HP:0100654) | 2.06189686 |
69 | Optic neuritis (HP:0100653) | 2.06189686 |
70 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.04922098 |
71 | Autoimmune thrombocytopenia (HP:0001973) | 2.04810068 |
72 | Congenital stationary night blindness (HP:0007642) | 2.01850279 |
73 | Lymphoma (HP:0002665) | 2.00062602 |
74 | Petechiae (HP:0000967) | 1.99023145 |
75 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.98242185 |
76 | Pulmonary infiltrates (HP:0002113) | 1.97606503 |
77 | True hermaphroditism (HP:0010459) | 1.96065844 |
78 | Pancreatic fibrosis (HP:0100732) | 1.95278388 |
79 | Delayed CNS myelination (HP:0002188) | 1.94572483 |
80 | Hypoplasia of the thymus (HP:0000778) | 1.94522615 |
81 | Recurrent bronchitis (HP:0002837) | 1.92668199 |
82 | Abnormal drinking behavior (HP:0030082) | 1.92367495 |
83 | Polydipsia (HP:0001959) | 1.92367495 |
84 | Hypoplasia of the uterus (HP:0000013) | 1.91830500 |
85 | Methylmalonic acidemia (HP:0002912) | 1.86641986 |
86 | Recurrent fungal infections (HP:0002841) | 1.86516349 |
87 | Myositis (HP:0100614) | 1.84841335 |
88 | Increased muscle lipid content (HP:0009058) | 1.82918191 |
89 | Oral leukoplakia (HP:0002745) | 1.82117992 |
90 | Lethargy (HP:0001254) | 1.82111923 |
91 | IgM deficiency (HP:0002850) | 1.81590660 |
92 | Neutropenia (HP:0001875) | 1.80861147 |
93 | Constricted visual fields (HP:0001133) | 1.76016040 |
94 | Keratoconjunctivitis (HP:0001096) | 1.75462396 |
95 | Polyuria (HP:0000103) | 1.73610505 |
96 | Respiratory failure (HP:0002878) | 1.71449515 |
97 | Exercise intolerance (HP:0003546) | 1.71394263 |
98 | Keratoconjunctivitis sicca (HP:0001097) | 1.69554279 |
99 | Leukodystrophy (HP:0002415) | 1.69345953 |
100 | Muscle fibrillation (HP:0010546) | 1.69222831 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 4.88331085 |
2 | KDR | 3.21413593 |
3 | MAP3K12 | 3.13719310 |
4 | TRIM28 | 3.02270832 |
5 | SIK3 | 2.95470530 |
6 | BCR | 2.82229657 |
7 | TESK2 | 2.64312890 |
8 | EIF2AK1 | 2.48548638 |
9 | EIF2AK3 | 2.46477819 |
10 | SCYL2 | 2.31564366 |
11 | ADRBK2 | 2.26458070 |
12 | VRK2 | 2.17518625 |
13 | ZAK | 2.17267147 |
14 | MST4 | 2.16953359 |
15 | MAP4K1 | 1.95127986 |
16 | TESK1 | 1.78043727 |
17 | MYLK | 1.77730637 |
18 | ITK | 1.75268800 |
19 | TLK1 | 1.71940518 |
20 | TEC | 1.63618235 |
21 | VRK1 | 1.62087254 |
22 | LIMK1 | 1.57680830 |
23 | GRK1 | 1.52858804 |
24 | BCKDK | 1.45510072 |
25 | FES | 1.41968991 |
26 | ERBB3 | 1.40928191 |
27 | NUAK1 | 1.37616290 |
28 | DAPK1 | 1.36675081 |
29 | BMPR1B | 1.34595895 |
30 | TSSK6 | 1.23827014 |
31 | RPS6KA4 | 1.23362775 |
32 | SRPK1 | 1.20972869 |
33 | TAOK3 | 1.13761249 |
34 | SYK | 1.06907605 |
35 | FRK | 1.04309707 |
36 | MAPK13 | 1.02437763 |
37 | PINK1 | 1.02117621 |
38 | WNK3 | 1.00144835 |
39 | CSNK1G3 | 0.99672115 |
40 | BTK | 0.95483834 |
41 | ACVR1B | 0.93934970 |
42 | WNK4 | 0.89336449 |
43 | STK16 | 0.84778110 |
44 | CSNK1G1 | 0.84169560 |
45 | PRKCQ | 0.83360066 |
46 | MAP2K6 | 0.82209847 |
47 | MAPKAPK3 | 0.80770606 |
48 | EIF2AK2 | 0.80052819 |
49 | IKBKE | 0.78369106 |
50 | CSNK1G2 | 0.77396585 |
51 | NEK1 | 0.77247025 |
52 | ZAP70 | 0.77167741 |
53 | PLK2 | 0.76620008 |
54 | GRK5 | 0.72465436 |
55 | KIT | 0.72325948 |
56 | LCK | 0.70345377 |
57 | PLK3 | 0.70272632 |
58 | LYN | 0.69600782 |
59 | GRK7 | 0.68055851 |
60 | TAF1 | 0.66854600 |
61 | IKBKB | 0.65669410 |
62 | CDK8 | 0.64987510 |
63 | CSNK1A1L | 0.59482724 |
64 | BUB1 | 0.57342594 |
65 | TNK2 | 0.56200074 |
66 | FLT3 | 0.55981338 |
67 | MAP2K7 | 0.52590349 |
68 | MAP3K11 | 0.51492570 |
69 | MAP4K2 | 0.50896657 |
70 | DAPK3 | 0.50839385 |
71 | RPS6KA5 | 0.50652720 |
72 | TIE1 | 0.50170722 |
73 | DYRK2 | 0.49548745 |
74 | INSRR | 0.49416589 |
75 | PRKCE | 0.49209696 |
76 | PIK3CA | 0.47053479 |
77 | PAK3 | 0.44700498 |
78 | TGFBR1 | 0.43804314 |
79 | GRK6 | 0.43199806 |
80 | IGF1R | 0.42944057 |
81 | CAMKK2 | 0.42441910 |
82 | CDC7 | 0.42062758 |
83 | PASK | 0.41573095 |
84 | PHKG1 | 0.40242211 |
85 | PHKG2 | 0.40242211 |
86 | ADRBK1 | 0.38135759 |
87 | CSK | 0.37911799 |
88 | MARK3 | 0.37708896 |
89 | CSF1R | 0.37420292 |
90 | HCK | 0.36683603 |
91 | PIK3CG | 0.36394877 |
92 | PDK2 | 0.33963322 |
93 | CAMK2A | 0.33776911 |
94 | PRKCA | 0.33200481 |
95 | CSNK1A1 | 0.31840939 |
96 | TBK1 | 0.31681796 |
97 | JAK3 | 0.31445670 |
98 | PRKACA | 0.29633844 |
99 | NME1 | 0.29188442 |
100 | MINK1 | 0.28580747 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 5.25008650 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.10707315 |
3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.05999797 |
4 | Protein export_Homo sapiens_hsa03060 | 3.05782429 |
5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.82613024 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.70578899 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 2.67822673 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.45277338 |
9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.26908079 |
10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.24259064 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.16588684 |
12 | RNA polymerase_Homo sapiens_hsa03020 | 2.00063179 |
13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98693429 |
14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.92356803 |
15 | Asthma_Homo sapiens_hsa05310 | 1.85917706 |
16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.82944853 |
17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.56323554 |
18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.52560323 |
19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.50744294 |
20 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.48084266 |
21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47950311 |
22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.45280245 |
23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44967897 |
24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.44935996 |
25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42528754 |
26 | Mismatch repair_Homo sapiens_hsa03430 | 1.36386498 |
27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34627145 |
28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.33165445 |
29 | Phototransduction_Homo sapiens_hsa04744 | 1.30285221 |
30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.26857654 |
31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21337822 |
32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20464183 |
33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16566230 |
34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.14805889 |
35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.12196829 |
36 | RNA degradation_Homo sapiens_hsa03018 | 1.01212530 |
37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99828828 |
38 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99443217 |
39 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.98685609 |
40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98056094 |
41 | Homologous recombination_Homo sapiens_hsa03440 | 0.96030898 |
42 | Measles_Homo sapiens_hsa05162 | 0.94323123 |
43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.94286234 |
44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92794121 |
45 | Purine metabolism_Homo sapiens_hsa00230 | 0.91503901 |
46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.88231669 |
47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85571276 |
48 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83163410 |
49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82012771 |
50 | Basal transcription factors_Homo sapiens_hsa03022 | 0.80161259 |
51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79100357 |
52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76218761 |
53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75921570 |
54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75545521 |
55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74275455 |
56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.74108956 |
57 | Peroxisome_Homo sapiens_hsa04146 | 0.72682828 |
58 | Legionellosis_Homo sapiens_hsa05134 | 0.71998200 |
59 | Salmonella infection_Homo sapiens_hsa05132 | 0.70002907 |
60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.68346260 |
61 | RNA transport_Homo sapiens_hsa03013 | 0.62911040 |
62 | Spliceosome_Homo sapiens_hsa03040 | 0.61145583 |
63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60889441 |
64 | Shigellosis_Homo sapiens_hsa05131 | 0.58833922 |
65 | DNA replication_Homo sapiens_hsa03030 | 0.58777031 |
66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58425360 |
67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57562955 |
68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57369704 |
69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.57317356 |
70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55609361 |
71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55189208 |
72 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52655010 |
73 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51578492 |
74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49172099 |
75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48938630 |
76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48632936 |
77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47425529 |
78 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47164228 |
79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46876852 |
80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46833381 |
81 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46643522 |
82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45805067 |
83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43787405 |
84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42900394 |
85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40895873 |
86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40599278 |
87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.40399041 |
88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39537621 |
89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39349624 |
90 | Base excision repair_Homo sapiens_hsa03410 | 0.39169885 |
91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35977882 |
92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30325086 |
93 | Alcoholism_Homo sapiens_hsa05034 | 0.23965458 |
94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.23225351 |
95 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22583984 |
96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.21717456 |
97 | Morphine addiction_Homo sapiens_hsa05032 | 0.21657209 |
98 | Taste transduction_Homo sapiens_hsa04742 | 0.21134954 |
99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.20896126 |
100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20434041 |